(Q33879558)

29 July 2017

title

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism (English)

1 reference

29 July 2017

1 reference

V J Moyes

1

1 reference

29 July 2017

J P Monson

series ordinal

2

1 reference

29 July 2017

S L Chew

series ordinal

3

1 reference

29 July 2017

S A Akker

series ordinal

4

1 reference

29 July 2017

publication date

26 May 2010

1 reference

International journal of endocrinology

29 July 2017

published in

1 reference

29 July 2017

volume

2010

1 reference

29 July 2017

page(s)

906163

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877200

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F906163

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F906163

A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F906163

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20585352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20585352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2010/906163

1 reference

29 July 2017

1 reference

29 July 2017

1 reference